135 related articles for article (PubMed ID: 1640957)
1. Membranous nephropathy--still a treatment dilemma.
Cameron JS
N Engl J Med; 1992 Aug; 327(9):638-9. PubMed ID: 1640957
[No Abstract] [Full Text] [Related]
2. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
3. Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy.
Ardiles LG; Mezzano SA
Clin Nephrol; 1996 Jun; 45(6):423. PubMed ID: 8793243
[No Abstract] [Full Text] [Related]
4. 20 years after methylprednisolone/chlorambucil treatment in idiopathic membranous nephropathy stage II-III with nephrotic syndrome.
Polenakovic M; Grcevska L; Dzikova S
Prilozi; 2006 Dec; 27(2):5-12. PubMed ID: 17211287
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Passerini P; Cagnoli L; Cesana B; Pozzi C; Pasquali S; Imbasciati E; Grassi C; Redaelli B
N Engl J Med; 1989 Jan; 320(1):8-13. PubMed ID: 2642605
[TBL] [Abstract][Full Text] [Related]
6. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.
Ponticelli C; Passerini P; Salvadori M; Manno C; Viola BF; Pasquali S; Mandolfo S; Messa P
Am J Kidney Dis; 2006 Feb; 47(2):233-40. PubMed ID: 16431252
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy.
Idasiak-Piechocka I; Oko A; Łochyńska-Bielecka K; Skrobańska B
Kidney Blood Press Res; 2009; 32(4):263-7. PubMed ID: 19776643
[TBL] [Abstract][Full Text] [Related]
8. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.
Ponticelli C; Altieri P; Scolari F; Passerini P; Roccatello D; Cesana B; Melis P; Valzorio B; Sasdelli M; Pasquali S; Pozzi C; Piccoli G; Lupo A; Segagni S; Antonucci F; Dugo M; Minari M; Scalia A; Pedrini L; Pisano G; Grassi C; Farina M; Bellazzi R
J Am Soc Nephrol; 1998 Mar; 9(3):444-50. PubMed ID: 9513907
[TBL] [Abstract][Full Text] [Related]
9. Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Grassi C; Limido D; Pasquali S; Passerini P; Volpini T; Locatelli F
Proc Eur Dial Transplant Assoc; 1983; 19():717-23. PubMed ID: 6348763
[TBL] [Abstract][Full Text] [Related]
10. Membranous allograft nephropathy. Remission of nephrotic syndrome with pulsed methylprednisolone and high-dose alternate-day steroids.
Johnston PA; Goode NP; Aparicio SR; Davison AM
Transplantation; 1993 Jan; 55(1):214-6. PubMed ID: 8420053
[No Abstract] [Full Text] [Related]
11. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
Goumenos DS; Katopodis KP; Passadakis P; Vardaki E; Liakopoulos V; Dafnis E; Stefanidis I; Vargemezis V; Vlachojannis JG; Siamopoulos KC
Am J Nephrol; 2007; 27(3):226-31. PubMed ID: 17389782
[TBL] [Abstract][Full Text] [Related]
12. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.
Ponticelli C; Zucchelli P; Imbasciati E; Cagnoli L; Pozzi C; Passerini P; Grassi C; Limido D; Pasquali S; Volpini T
N Engl J Med; 1984 Apr; 310(15):946-50. PubMed ID: 6366560
[TBL] [Abstract][Full Text] [Related]
13. [Controlled study of treatment of steroids and chlorambucil, in alternate months, for membranous nephropathy and focal glomerulosclerosis. Preliminary evaluation of the results].
Imbasciati E; Cagnoli L; Case N; Pasquali S; Di Filippo G; Limido D; Cornalba L; Volpini T; Pozzi C; Zuccelli P; Ponticelli C
Minerva Nefrol; 1980; 27(4):571-5. PubMed ID: 7019771
[No Abstract] [Full Text] [Related]
14. Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide.
Reichert LJ; Huysmans FT; Assmann K; Koene RA; Wetzels JF
Ann Intern Med; 1994 Sep; 121(5):328-33. PubMed ID: 8042821
[TBL] [Abstract][Full Text] [Related]
15. Membranous nephropathy associated with acute myeloid leukemia.
Sahiner S; Ayli MD; Yüksel C; Oneç K; Abayli E
Transplant Proc; 2004 Nov; 36(9):2618-9. PubMed ID: 15621104
[TBL] [Abstract][Full Text] [Related]
16. [Long-term outcome of nephrotic syndrome due to primary membranous nephropathy].
Fujimoto S; Yamamoto Y; Wakisaka O; Hisanaga S; Miyata J; Tanaka K
Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):687-93. PubMed ID: 3172567
[No Abstract] [Full Text] [Related]
17. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
Ponticelli C; Passerini P
Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
[TBL] [Abstract][Full Text] [Related]
18. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.
Ponticelli C; Zucchelli P; Passerini P; Cesana B; Locatelli F; Pasquali S; Sasdelli M; Redaelli B; Grassi C; Pozzi C
Kidney Int; 1995 Nov; 48(5):1600-4. PubMed ID: 8544420
[TBL] [Abstract][Full Text] [Related]
19. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
Knotková V; Nĕmecek K; Tarayeva IE; Krasnova TN
Vnitr Lek; 1993 Dec; 39(12):1157-63. PubMed ID: 8310664
[TBL] [Abstract][Full Text] [Related]
20. The advantages of immunosuppressive therapy in renal disease.
Zucchelli P
Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]